跳至主要内容
临床试验/NL-OMON31914
NL-OMON31914尚未招募4 期

The effect of short term Topiramate treatment on insulin secretion, glucose- and lipid metabolism in obese women - Effect of Topiramate on glucose and lipid metabolism in obese women

Top Institute Pharma0 个研究点目标入组 13 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
13

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Female volunteers
  • Age > 18 years and < 70 years
  • BMI > 27 kg/m2 and < 44 kg/m2
  • Fasting serum glucose (FSG) 6.1-7 mmol/L

排除标准

  • FSG >7 mmol/L
  • Psychiatric disorders and/or use of antipsychotic or antidepressants drugs at present or in the past.
  • Any significant chronic disease
  • Any significant abnormal laboratory results found during the medical screening procedure
  • Renal, hepatic or endocrine disease (including DM)
  • Use of medication known to influence glucose and/or FFA metabolism
  • Premenopausal women who do not use oral contraceptives or intrauterine device
  • Recent weight changes or attempts to loose weight (> 3 kg weight gain or loss, within the last 3 months)
  • Difficulties to insert an intravenous catheter
  • Severe claustrophobia (ventilated hood)
  • Recent blood donation (within the last 3 months)
  • Recent participation in other research projects (within the last 3 months), participation in 2 or more projects in one year

研究者

发起方
Top Institute Pharma

相似试验